Dashboard
Manage Tickers

ROIVRoivant Sciences Ltd.

Nasdaq roivant.com


$ 11.78 $ -0.10 (-0.84 %)    

Monday, 26-Aug-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.46 $ -4.66 (-0.97 %)
DIA $ 412.48 $ 0.89 (0.22 %)
SPY $ 560.78 $ -1.34 (-0.24 %)
TLT $ 98.13 $ -0.25 (-0.25 %)
GLD $ 232.75 $ 0.74 (0.32 %)
$ 11.78
$ 11.87
$ 11.78 x 1,000
$ 11.79 x 1,000
$ 11.74 - $ 11.92
$ 8.25 - $ 13.24
2,702,611
na
8.71B
$ 0.86
$ 1.84
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-09-2024 06-30-2024 10-Q
2 05-30-2024 03-31-2024 10-K
3 02-13-2024 12-31-2023 10-Q
4 11-13-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 06-28-2023 03-31-2023 10-K
7 02-13-2023 12-31-2022 10-Q
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 06-28-2022 03-31-2022 10-K
11 02-14-2022 12-31-2021 10-Q
12 11-15-2021 09-30-2021 10-Q
13 09-21-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-roivant-sciences-maintains-18-price-target
HC Wainwright & Co. Reiterates Buy on Roiv...
08/19/2024 10:43:13

HC Wainwright & Co. analyst Douglas Tsao reiterates Roivant Sciences (NASDAQ:ROIV) with a Buy and maintains $18 price ta...

roivant-sciences-q1-2025-adj-eps-017-beats-026-estimate-sales-55132m-beat-31500m-estimate
Roivant Sciences Q1 2025 Adj. EPS $(0.17) ...
08/08/2024 11:08:03

Roivant Sciences (NASDAQ:ROIV) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0....

piper-sandler-maintains-overweight-on-roivant-sciences-raises-price-target-to-22
Piper Sandler Maintains Overweight on Roiv...
07/10/2024 14:09:59

Piper Sandler analyst Allison Bratzel maintains Roivant Sciences (NASDAQ:ROIV) with a Overweight and raises the price target...

evaluating-roivant-sciences-insights-from-6-financial-analysts
Evaluating Roivant Sciences: Insights From...
06/18/2024 15:00:13

cantor-fitzgerald-reiterates-overweight-on-roivant-sciences
Cantor Fitzgerald Reiterates Overweight on...
06/18/2024 14:07:26

Cantor Fitzgerald analyst Louise Chen reiterates Roivant Sciences (NASDAQ:ROIV) with a Overweight.

the-analyst-verdict-roivant-sciences-in-the-eyes-of-6-experts
The Analyst Verdict: Roivant Sciences In T...
05/31/2024 14:00:16

hc-wainwright--co-reiterates-buy-on-roivant-sciences-maintains-18-price-target
HC Wainwright & Co. Reiterates Buy on Roiv...
05/31/2024 10:38:57

HC Wainwright & Co. analyst Douglas Tsao reiterates Roivant Sciences (NASDAQ:ROIV) with a Buy and maintains $18 price ta...

roivant-sciences-q4-2024-gaap-eps-019-beats-032-estimate-sales-28930m-miss-32101m-estimate
Roivant Sciences Q4 2024 GAAP EPS $(0.19) ...
05/30/2024 11:02:13

Roivant Sciences (NASDAQ:ROIV) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0....

vivek-ramaswamy-breathes-new-life-into-beaten-down-buzzfeed-stock-whats-going-on
Vivek Ramaswamy Breathes New Life Into Bea...
05/22/2024 12:04:01

BuzzFeed shares surged after Vivek Ramaswamy acquired a 7.7% stake for $3.2 million.

roivant-and-kinevant-sciences-complete-enrollment-in-resolve-lung-phase-2-study-evaluating-namilumab-for-chronic-pulmonary-sarcoidosis
Roivant And Kinevant Sciences Complete Enr...
04/25/2024 12:08:24

critical-insights-from-roivant-sciences-analyst-ratings-what-you-need-to-know
Critical Insights From Roivant Sciences An...
04/22/2024 15:01:12

hc-wainwright--co-reiterates-buy-on-roivant-sciences-maintains-18-price-target
HC Wainwright & Co. Reiterates Buy on Roiv...
04/22/2024 10:34:04

HC Wainwright & Co. analyst Douglas Tsao reiterates Roivant Sciences (NASDAQ:ROIV) with a Buy and maintains $18 price ta...

goldman-sachs-maintains-buy-on-roivant-sciences-raises-price-target-to-18
Goldman Sachs Maintains Buy on Roivant Sci...
04/03/2024 15:18:11

Goldman Sachs analyst Corinne Jenkins maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $...

hc-wainwright--co-maintains-buy-on-roivant-sciences-raises-price-target-to-18
HC Wainwright & Co. Maintains Buy on Roiva...
04/03/2024 11:05:41

HC Wainwright & Co. analyst Douglas Tsao maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target...

deutsche-bank-maintains-buy-on-roivant-sciences-raises-price-target-to-15
Deutsche Bank Maintains Buy on Roivant Sci...
04/03/2024 09:14:44

Deutsche Bank analyst Neena Bitritto-Garg maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target fr...

vivek-ramaswamy-founded-roivants-anti-inflammatory-drug-aces-mid-stage-study
Vivek Ramaswamy-Founded Roivant's Anti-Inf...
04/02/2024 16:31:51

Roivant Sciences and Priovant Therapeutics report Phase 2 results for brepocitinib in treating non-anterior non-infectious uvei...

roivant-sciences-reveals-board-authorization-for-up-to-15b-share-repurchase-program-including-repurchase-of-entire-sumitomo-pharma-stake-for-648m
Roivant Sciences Reveals Board Authorizati...
04/02/2024 11:12:00

Sumitomo Pharma repurchase reduces shares outstanding by 9%

roivant-announces-positive-neptune-study-results-for-brepocitinib-in--non-infectious-uveitis
Roivant Announces Positive NEPTUNE Study R...
04/02/2024 11:10:22

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
03/29/2024 17:35:25

Core News & Articles
Roivant Sciences To Replace Sunrun In S&P ...
03/26/2024 21:20:46

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION